PT  - JOURNAL ARTICLE
AU  - Junjun Huang
AU  - Xiaoyu Yang
AU  - Fangfang Fan
AU  - Yan Hu
AU  - Xi Wang
AU  - Sainan Zhu
AU  - Guanhua Ren
AU  - Guangfa Wang
TI  - Outdoor air pollution and the risk of asthma exacerbations in single lag0 and lag1 exposure patterns: A systematic review and meta-analysis
AID  - 10.1101/2021.02.04.21251113
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.04.21251113
4099  - http://medrxiv.org/content/early/2021/02/05/2021.02.04.21251113.short
4100  - http://medrxiv.org/content/early/2021/02/05/2021.02.04.21251113.full
AB  - Background Asthma exacerbations accelerate the disease progression, as well as increases the incidence of hospitalizations and deaths. There have been studies on the effects of outdoor air pollution and asthma exacerbations; however, evidence regarding single lag0 and lag1 exposure patterns is inconclusive.Objective To synthesize evidence regarding the relationship between outdoor air pollution and the asthma exacerbation risk in single lag0 and lag1 exposure patterns.Methods We performed a systematic literature search using PubMed, Embase, Cochrane Library, Web of Science, ClinicalTrials, China National Knowledge Internet, Chinese BioMedical, and Wanfang databases until August 1st, 2020. Additionally, we reviewed the reference lists of the relevant articles. Two authors independently evaluated the eligible articles and performed structured extraction of relevant information. Pooled relative risks (RRs) and 95% confidence intervals (CIs) of lag0 and lag1 exposure patterns were estimated using the random-effect models.Results Eighty-four studies met the eligibility criteria and provided sufficient information for meta-analysis. Outdoor air pollutants were associated with significantly increased risks of asthma exacerbations in both single lag0 and lag1 exposure patterns [lag0: RR (95%CI) (pollutants), 1.057(1.011, 1.103) (air quality index; AQI), 1.007(1.005, 1.010) (PM2.5), 1.009(1.005, 1.012) (PM10), 1.010(1.006, 1.014) (NO2), 1.030(1.011, 1.048) (CO), 1.005(1.002, 1.009) (O3); lag1: RR (95%CI) (pollutants), 1.064(1.022, 1.106) (AQI), 1.005(1.002, 1.008) (PM2.5), 1.007(1.004, 1.011) (PM10), 1.008(1.004, 1.012) (NO2), 1.025(1.007, 1.042) (CO), 1.010(1.006, 1.013) (O3)], except SO2 [lag0: RR (95%CI), 1.004(1.000, 1.007); lag1: RR (95%CI), 1.003(0.999, 1.006)]. Subgroup analyses revealed stronger effects in children and asthma exacerbations associated with other events (including symptoms, lung function changes, and medication use as required).Conclusion These findings demonstrate that outdoor air pollution significantly increases the asthma exacerbation risk in single lag0 and lag1 exposure patterns.PROSPERO registration number CRD42020204097 (https://www.crd.york.ac.uk/PROSPERO).Strengths and limitations of this studyWe performed a systematic literature search of six databases (with no specified start date or language limitation).Secondary references were included.Publication bias was assessed by applying Begg’s and Egger’s tests.This study focused on the association between outdoor air pollution and the asthma exacerbation risk in single lag0 and lag1 exposure patterns.There were few available studies regarding the AQI, other events, and death analyses.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCRD42020204097Funding StatementThis work was supported by grant 2018CR02 from the Youth Clinical Research Project of Peking University First Hospital. The funding bodies did not participate in study design or data collection and analysis. Additionally, the funding bodies do not participate in writing the manuscript and decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research is a systematic review,and dose not need a IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available on reasonable request.